Following a surge of 52.47% during regular trading session on Tuesday, Polyrizon Ltd (NASDAQ: PLRZ) witnessed a dip of 12.02% ...

Lumos Diagnostics signs exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US.

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant ...

Amgen's expanding rare disease and biosimilar portfolios, coupled with growth potential and dividend history make AMGN stock ...

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Their first product, Illuccix, is a diagnostic imaging agent that allows PET scanners to light up the prostate cancer cells ...

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

Liquidia stock earns the No. 246 rank among its peers in the Medical-Biomed/Biotech industry group. Exelixis EXEL, TG Therapeutics TGTX and Inhibrx Biosciences INBX are among the top 5 highly rated ...

Jack Chan, EY China’s chairman, describes how the HKEX and SFC’s new Technology Enterprises Channel has streamlined the ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company” or 'Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a ...

Aquaculture group Camaroe Bhd has got the green light from Bursa Malaysia Securities to list on the ACE Market of the stock ...